ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Ab Science

Ab Science (AB)

0.791
-0.031
( -3.77% )
Updated: 02:14:08

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.791
Bid
0.791
Offer
0.80
Volume
66,583
0.79 Day's Range 0.823
0.79 52 Week Range 4.465
Market Cap
Previous Close
0.822
Open
0.822
Last Trade
115
@
0.791
Last Trade Time
02:14:08
Financial Volume
-
VWAP
-
Average Volume (3m)
35,025
Shares Outstanding
52,071,069
Dividend Yield
-
PE Ratio
-3.43
Earnings Per Share (EPS)
-0.23
Revenue
970k
Net Profit
-11.99M

About Ab Science

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Paris, Paris, Fra
Founded
-
Ab Science is listed in the Pharmaceutical Preparations sector of the Euronext with ticker AB. The last closing price for Ab Science was 0.82 €. Over the last year, Ab Science shares have traded in a share price range of 0.79 € to 4.465 €.

Ab Science currently has 52,071,069 shares in issue. The market capitalisation of Ab Science is 42.80 € million. Ab Science has a price to earnings ratio (PE ratio) of -3.43.

AB Latest News

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN...

AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose

AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT UN AVIS...

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease

PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL DISEASE THIS DECISION FURTHER STRENGTHENS MASITINIB’S...

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL...

AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA

AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA COMMUNIQUE DE PRESSE AB SCIENCE FAIT LE POINT SUR LA DEMANDE...

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION OF MASITINIB IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Paris, 17 October, 2024...

AB Science : Résultats financiers semestriels au 30 juin 2024 et point sur les activités d’AB Science

AB Science : Résultats financiers semestriels au 30 juin 2024 et point sur les activités d’AB Science          COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS FINANCIERS AU PREMIER SEMESTRE...

AB Science: Revenues for the first half of 2024 and update on AB Science’s activities

AB Science: Revenues for the first half of 2024 and update on AB Science’s activities          PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2024 AND THE KEY EVENTS...

AB Science: Revenues for the first half of 2024 and update on AB Science’s activities

         PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2024 AND THE KEY EVENTS OF THE PERIOD Clinical development Masitinib platform: Ongoing re-examination by...

AB Science annonce avoir réalisé le règlement livraison de sa dernière augmentation de capital de 5,0 millions d’euros

AB Science annonce avoir réalisé le règlement livraison de sa dernière augmentation de capital de 5,0 millions d’euros COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE AVOIR REALISE LE REGLEMENT LIVRAISON...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.12-13.172338090.9110.9380.79543020.86686287DE
4-0.195-19.77687626770.9861.050.79400380.93896874DE
12-0.287-26.62337662341.0781.0780.79350250.97805967DE
26-1.334-62.77647058822.1252.1550.79702271.25149884DE
52-2.099-72.62975778552.894.4650.79997482.23317557DE
156-11.459-93.542857142912.2513.340.79953874.70619732DE
260-4.239-84.27435387675.0321.750.791449368.45867132DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BIDSGascogne DS
0.003 €
(66.67%)
70.48k
ALMASMastrad
0.0114 €
(32.56%)
6.14M
ALCBICrypto Blockchain Industries
0.271 €
(17.83%)
1.01M
ALTBGBlockchain GP
0.343 €
(12.83%)
3.33M
ALEXPOne Experience
0.338 €
(12.67%)
550
EBUSEbusco Holding NV
0.875 €
(-28.63%)
3.04M
FINMFinanciere Marjos
0.076 €
(-20.83%)
110
CNVCnova NV
0.80 €
(-19.19%)
800
MLCMGCMG Clean Tech
1.00 €
(-17.36%)
1.76k
ATOAtos SE
0.1601 €
(-16.83%)
5.94M
ALNEVNeovacs
0.0002 €
(0.00%)
51M
ATODSAtos SE
0.0041 €
(0.00%)
26.93M
BCPBanco Comercial Portugues SA
0.4449 €
(1.16%)
26.13M
ALTDTonner Drones
0.01 €
(8.70%)
14.35M
ALVERVergnet
0.0044 €
(-8.33%)
12.18M

Discussion

View Full Feed
JusDePomme JusDePomme 5 minutes ago
These small flipper sellers looks like a donkey
SINC
helpx helpx 5 minutes ago
Yep my target is 0.003 by xmas
CYBL
mankind mankind 5 minutes ago
I think changing your mind a lot makes zero sense if your strategy is based on fundamentals? Watching intraday price movement is 100% noise to ANY strategy based on P/E, book value etc. , which you are always pointing at. We now and have been in a market that rewards the crappiest of stocks (fundame
snow snow 5 minutes ago
Mr Smith I followed SPZI closely during that period after having first sold all my almost 50 million shares at a a profit of more than 50,000 dollars. I later bought back a much lower number of shares. I was then uncertain if Mr Strickland was honest or not.
SPZI
blackhawks blackhawks 6 minutes ago
Pic of MSNBC hosts meeting at Mar a Lago






https://ichef.bbci.co.uk/ace/ws/640/cpsprodpb/11B1C/production/_88667427_a0007cf0-a392-4d0f-b265-b8c103ef8f01.jpg

https://www.democraticunderground.com/100219748230
getmoreshares getmoreshares 6 minutes ago
#3 most active! ? https://ih.advfn.com/markets/usotc/regular
CGAC
glenn1919 glenn1919 6 minutes ago
MULN....................slapthebid.......................https://stockcharts.com/h-sc/ui?s=muln&p=W&yr=1&mn=3&dy=0&id=p96837884856
MULN
blackhawks blackhawks 6 minutes ago
Pic of MSNBC hosts meeting at Mar a Lago






https://ichef.bbci.co.uk/ace/ws/640/cpsprodpb/11B1C/production/_88667427_a0007cf0-a392-4d0f-b265-b8c103ef8f01.jpg

https://www.democraticunderground.com/100219748230
mineanddine mineanddine 6 minutes ago
Dilution scam 
HIRU
FatStrat FatStrat 6 minutes ago
Yes! Wanted some sub 4's but missed my chance doing chores 😠 
UVIX
JusDePomme JusDePomme 6 minutes ago
SINC .0014 wow....super thin level 2
SINC
somberfox somberfox 6 minutes ago
Just waiting for ole arc trade and the other twitter junkie company to go all in and spend "ALL OF THEIR OTC MONEY" on these "eye dropping" dips that... started at the high 2s.
CLNV
Implanting Implanting 7 minutes ago
Conversation between David Lin and a mining exec., some good discussion from this Guy about junior miners and even though I don't agree with everything he's saying, I found him spot on about what he says starting at about 12:00 into the interview when they begin talking about the performance of gold
FFMGF
Steady_T Steady_T 7 minutes ago
It is a bit more complicated that what "Gemini" told you.

https://viewpoint.pwc.com/dt/us/en/pwc/pwc_sec_volume/pwc_sec_volume_US/3000_registration_an_US/sec_3125_the_acceler_US.html#pwc-topic.dita_3ef03b99-3616-4534-84bb-a89ba0363e18 Flow chart for determining filing status.
AVXL
DiscoverGold DiscoverGold 7 minutes ago
Money managers Remain Bullish with their exposure to the US Equity markets since last week...
studentaid.gov/universal-navigation/assets/us_flag_small.png DiscoverGold

NAAIM Exposure Index

November 21, 2024 www.naaim.org/wp-content/themes/naaim/favicon.ic
JusDePomme JusDePomme 7 minutes ago
Sinc looks wow
SINC
Rambo Rell Rambo Rell 7 minutes ago
$ILLR 💼 Triller is an undervalued gem in the social media space, with vast untapped assets ready for monetization. Positioned for growth through live events, music, and Web3 innovations, @Triller is creating a unique ecosystem for creators and users alike. Investors, this is a rare opportuni
ILLR
Lacey1 Lacey1 7 minutes ago
Cilantro is a great natural detox for heavy metals. Vit C infusions to kickstart your immune system. Good luck.
blackhawks blackhawks 7 minutes ago
Pic of MSNBC hosts meeting at Mar a Lago






https://ichef.bbci.co.uk/ace/ws/640/cpsprodpb/11B1C/production/_88667427_a0007cf0-a392-4d0f-b265-b8c103ef8f01.jpg

https://www.democraticunderground.com/100219748230
Rambo Rell Rambo Rell 7 minutes ago
$ILLR 💼 Triller is an undervalued gem in the social media space, with vast untapped assets ready for monetization. Positioned for growth through live events, music, and Web3 innovations, @Triller is creating a unique ecosystem for creators and users alike. Investors, this is a rare opportuni
ILLR
capgain capgain 8 minutes ago
Don't worry.

Life is good right now, especially for my bookie lol!
MoneyMan MoneyMan 8 minutes ago
Imagine a meeting with Elon
https://x.com/KateMonroeCEO/status/1859621855973269960
CEOS
PEACHMAN PEACHMAN 8 minutes ago
IFUS is a legitimate company that does not need or want my help.

Clowns like you should work in the circus and scare children,or just continue to spend the rest of your life bashing multiple stocks on multiple boards for you market maker bosses.


https://investor
IFUS